Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?

Disease modification achievement in patients with lupus nephritis in a real-life setting: mission impossible?

Objective A preliminary definition of disease modification (DM) in lupus nephritis (LN) was recently developed focusing on long-term remission and damage prevention, with minimal treatment-associated toxicity. We aimed to further specify aspects of DM criteria in LN, assess DM achievement in a real-...

Full description

Bibliographic Details
Main Authors:	Maria G Tektonidou, Petros P Sfikakis, John Boletis, Smaragdi Marinaki, Alexandros Panagiotopoulos, Ioannis Michelakis, Eleni Kapsia
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-04-01
Series:	RMD Open
Online Access:	https://rmdopen.bmj.com/content/9/2/e003158.full

Similar Items

New Insights Into an Overlooked Entity: Long-Term Outcomes of Membranous Lupus Nephritis From a Single Institution Inception Cohort
by: Eleni Kapsia, et al.
Published: (2022-04-01)

Predictors of Early Response, Flares, and Long-Term Adverse Renal Outcomes in Proliferative Lupus Nephritis: A 100-Month Median Follow-Up of an Inception Cohort
by: Eleni Kapsia, et al.
Published: (2022-08-01)

Clinical impact of repeat renal biopsies in patients with lupus nephritis: Renal biopsy is essential especially later in the course of the disease
by: Smaragdi Marinaki, et al.
Published: (2020-01-01)

Treatment of HIV-Associated Lupus-like Membranous Nephropathy with Tacrolimus: A Case Report and Review of the Literature
by: Ioannis Kofotolios, et al.
Published: (2023-02-01)

Τhe Impact of Pre-Transplant Kidney Biopsy on the Evaluation of Prospective Living Kidney Donors
by: Smaragdi Marinaki, et al.
Published: (2023-04-01)

Glomerular Diseases Associated with Malignancies: Histopathological Pattern and Association with Circulating Autoantibodies
by: Sophia Lionaki, et al.
Published: (2020-05-01)

Mission Impossible?
by: Nord Lars W., et al.
Published: (2003-11-01)

27 Disease modification in lupus nephritis
by: Manuel Praga
Published: (2023-09-01)

Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
by: Sophia Lionaki, et al.
Published: (2021-01-01)

The Evolution of Living Donor Nephrectomy Program at A Hellenic Transplant Center. Laparoscopic vs. Open Donor Nephrectomy: Single-Center Experience
by: Spyridon Vernadakis, et al.
Published: (2021-03-01)

Sociodemographic Disparities in Adults with Kidney Failure: A Meta-Analysis
by: Ioannis Bellos, et al.
Published: (2024-01-01)

Plasma Exchange in ANCA-Associated Vasculitis: A Narrative Review
by: Stathis Tsiakas, et al.
Published: (2021-11-01)

Walk the talk? It's mission impossible
by: Abd Razak, Dzulkifli
Published: (2006)

Mission: impossible III [videorecording] /
by: Paramount Pictures Corporation
Published: (2006)

Patient satisfaction - Mission impossible
by: Ashley Thomas Jacob
Published: (2017-01-01)

A Systematic Review of COVID-19 Infection in Kidney Transplant Recipients: A Universal Effort to Preserve Patients’ Lives and Allografts
by: Smaragdi Marinaki, et al.
Published: (2020-09-01)

De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor
by: Smaragdi Marinaki, et al.
Published: (2021-12-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)

Public sector management : mission impossible? /
by: 252866 Chaston, Ian
Published: (2011)

Decent, Inclusive, and Green? Mission Impossible?
by: Vassil Kirov
Published: (2023-07-01)

Quality assessment in surgery: mission impossible?
by: Clavien Pierre-Alain, et al.
Published: (2010-11-01)

Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations
by: Maria G Tektonidou, et al.
Published: (2023-02-01)

P92 Quantifying the unmet need in lupus nephritis: EULAR/ERA- EDTA treatment targets, flares, and treatment modifications in the first year in a multicenter observational study
by: Maria Tektonidou, et al.
Published: (2024-03-01)

Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis
by: Muhammed Mubarak
Published: (2013-01-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-12-01)

Management of Lupus Nephritis
by: Farah Tamirou, et al.
Published: (2021-02-01)

Lupus Nephritis and Dysbiosis
by: Marta Monticolo, et al.
Published: (2023-04-01)

Tubulointerstitial lupus nephritis
by: Ala Ali, et al.
Published: (2013-01-01)

Management of Lupus Nephritis
by: Merkel F, et al.
Published: (2000-01-01)

19 Lupus nephritis
by: Liz Lightstone, et al.
Published: (2021-04-01)

Pediatric lupus nephritis
by: Sergio Veloso Brant Pinheiro, et al.
Published: (2018-11-01)

The impersonation of personality: Film as philosophy in 'Mission - Impossible'
by: Mulhall, S
Published: (2006)

Metaverse influence on transportation: A mission impossible?
by: Emmanuel Mogaji
Published: (2023-11-01)

Youth in Elderly Care Sector – Mission Impossible?
by: Sandra Krutulienė, et al.
Published: (2022-11-01)

Therapeutic Options for Recurrence of Primary Focal Segmental Glomerulonephritis (FSGS) in the Renal Allograft: Single-Center Experience
by: Kalliopi Vallianou, et al.
Published: (2021-01-01)

A Patient with Cryoglobulinemic Membranoproliferative GN (MPGN) Who Survived COVID-19 Disease: Case Presentation and Current Data of COVID-19 Infection in Dialysis and Transplanted Patients in Greece
by: Smaragdi Marinaki, et al.
Published: (2020-07-01)

A case report of hypocomplementemic urticarial vasculitis presenting with membranoproliferative glomerulonephritis
by: Kalliopi Vallianou, et al.
Published: (2020-08-01)

Arterial Stiffness in Patients With Renal Transplantation; Associations With Co-morbid Conditions, Evolution, and Prognostic Importance for Cardiovascular and Renal Outcomes
by: Maria Korogiannou, et al.
Published: (2019-05-01)

Penanganan Tuberkulosis Resistan Obat pada Daerah Terpencil: Mission Impossible? [Management of Drug-Resistant Tuberculosis in Isolated Area: Mission Impossible?]
by: Ivan Banjuradja, et al.
Published: (2017-01-01)

Assessment of mRNA Vaccine Immunogenicity in Solid Organ Transplant Recipients
by: Paraskevi Tsoutsoura, et al.
Published: (2023-06-01)